Your browser doesn't support javascript.
loading
Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.
Sperlazza, Justin; Galeotti, Jonathan; Hucks, George; Alexander, Thomas B.
Afiliação
  • Sperlazza J; Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Galeotti J; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Hucks G; Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Alexander TB; Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Pediatr Blood Cancer ; 70(11): e30645, 2023 11.
Article em En | MEDLINE | ID: mdl-37638847
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Citarabina Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Citarabina Idioma: En Ano de publicação: 2023 Tipo de documento: Article